Ventrus Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
- Website
- http://www.ventrusbio.com
Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects
Phase 1
Completed
- Conditions
- CLARITHROMYCIN/DILTIAZEM [VA Drug Interaction]
- Interventions
- First Posted Date
- 2014-03-06
- Last Posted Date
- 2014-04-14
- Lead Sponsor
- Ventrus Biosciences, Inc
- Target Recruit Count
- 24
- Registration Number
- NCT02080780
- Locations
- 🇺🇸
TKL Research, Paramus, New Jersey, United States
A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test Design
Phase 1
- Conditions
- Skin Irritation
- Interventions
- Drug: Vehicle CreamDrug: 0.1% solution o sodium lauryl sulfate (SLS)Drug: Saline 0.9%
- First Posted Date
- 2013-03-29
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Ventrus Biosciences, Inc
- Target Recruit Count
- 30
- Registration Number
- NCT01821274
- Locations
- 🇺🇸
TKL Research, Paramus, New Jersey, United States
An Open-Label, Single- and Multi-Dose Pharmacokinetic (PK) Study of Oral Diltiazem and Topical Diltiazem Hydrochloride
Phase 1
- Conditions
- Adult Subjects With Anal Fissures.
- Interventions
- First Posted Date
- 2013-03-22
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Ventrus Biosciences, Inc
- Target Recruit Count
- 12
- Registration Number
- NCT01816191
- Locations
- 🇺🇸
Wake Research Associates, Raleigh, North Carolina, United States
Topical Safety Study of Topical Diltiazem Hydrochloride
Phase 1
- Conditions
- Diltiazem Skin Sensitivity.
- Interventions
- Drug: Saline (0.9%)Drug: Vehicle CreamDrug: 0.1% solution of sodium lauryl sulfate (SLS)
- First Posted Date
- 2013-03-22
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Ventrus Biosciences, Inc
- Target Recruit Count
- 200
- Registration Number
- NCT01816529
- Locations
- 🇺🇸
TKL Research, Paramus, New Jersey, United States
Efficacy and Safety Study With Diltiazem Hydrochloride Cream to Treat Anal Fissures
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2014-01-23
- Lead Sponsor
- Ventrus Biosciences, Inc
- Target Recruit Count
- 434
- Registration Number
- NCT01690221
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸Investigative Clinical Research, Annapolis, Maryland, United States
🇺🇸Advance Medical Research Center, Miami, Florida, United States
Efficacy Study of Iferanserin to Treat Hemorrhoids
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2013-08-21
- Lead Sponsor
- Ventrus Biosciences, Inc
- Target Recruit Count
- 121
- Registration Number
- NCT01483833
- Locations
- 🇩🇪
Prof. Alexander Herold, MD, Mannheim, Germany
Efficacy and Safety Study to Treat Subjects With Symptomatic Internal Hemorrhoids
Phase 3
Terminated
- Conditions
- Internal Hemorrhoids
- Interventions
- First Posted Date
- 2011-05-18
- Last Posted Date
- 2014-01-28
- Lead Sponsor
- Ventrus Biosciences, Inc
- Target Recruit Count
- 403
- Registration Number
- NCT01355874
- Locations
- 🇺🇸
Central Sooner, Norman, Oklahoma, United States
🇺🇸MRA, Miami, Florida, United States
🇺🇸Clin Res Nevada, Las Vegas, Nevada, United States
© Copyright 2025. All Rights Reserved by MedPath